The second season of Research Matters, a Cornell video podcast, drops today, with a way-too-relevant episode on why we don't always do the things we know we should.
Cornell researchers successfully ramped up the body’s own immune response to fight melanoma at the tail end of a targeted cancer therapy, when tumors commonly become resistant to these treatments.
Prostate tumors can rewire amino acid metabolism to override the normal brakes on cholesterol production, a process that may fuel hormone therapy resistance, according to Weill Cornell Medicine researchers.
Weill Cornell Medicine celebrated the incoming physician assistant students in the Class of 2028 and first-year medical students in the Class of 2030 Aug. 18 during two White Coat Ceremonies.
Researchers developed an ultrafast-dissolving nanofiber film that can deliver a cocktail of three drugs so quickly and effectively, 90% of the formulation is released in less than two seconds.
Traumatic brain injury in Pakistan is associated with a high risk of death and disability long after the initial injury, even in mild to moderate cases.
